132 related articles for article (PubMed ID: 19052182)
21. Hepatitis B virus rtA181T/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T/sW172* mutation.
Zhao L; Li X; Cheng Y; Chen R; Shao J; Zhou Y; Li Q; Liao H; Zhao Y; Liu L; Su H; Liu Y; Liu Y; Xu D
Antiviral Res; 2018 Jun; 154():26-34. PubMed ID: 29630974
[TBL] [Abstract][Full Text] [Related]
22. Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.
Degertekin B; Hussain M; Tan J; Oberhelman K; Lok AS
J Hepatol; 2009 Jan; 50(1):42-8. PubMed ID: 19019484
[TBL] [Abstract][Full Text] [Related]
23. Revisiting HBV resistance to entecavir with a phenotypic approach.
Marlet J; Lier C; Roch E; Maugey M; Moreau A; Combe B; Lefeuvre S; d'Alteroche L; Barbereau D; Causse X; Bastides F; Bachelier MN; Brand D; Gaudy-Graffin C
Antiviral Res; 2020 Sep; 181():104869. PubMed ID: 32735901
[TBL] [Abstract][Full Text] [Related]
24. Large-scale survey of naturally occurring HBV polymerase mutations associated with anti-HBV drug resistance in untreated patients with chronic hepatitis B.
Mirandola S; Campagnolo D; Bortoletto G; Franceschini L; Marcolongo M; Alberti A
J Viral Hepat; 2011 Jul; 18(7):e212-6. PubMed ID: 21692935
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of a line probe assay for identification of hepatitis B virus precore variants in serum from chronic hepatitis B carriers.
Cameron-Wilson CL; Muir P; Ballard AL; Corden S; Boxall EH; Sablon E; Stuyver L
J Virol Methods; 2003 Dec; 114(1):97-103. PubMed ID: 14599684
[TBL] [Abstract][Full Text] [Related]
26. [Detection of HBV resistant mutations related to lamivudine, adefovir and entecavir by reverse hybridization technique].
Liu YC; Zhang WL; Hu Y; Zhao L; Lai GQ; Hu JL; Yang F; Huang AL
Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):414-8. PubMed ID: 20587309
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.
Kim HS; Han KH; Ahn SH; Kim EO; Chang HY; Moon MS; Chung HJ; Yoo W; Kim SO; Hong SP
Antivir Ther; 2005; 10(3):441-9. PubMed ID: 15918335
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection.
Karatayli E; Karatayli SC; Cinar K; Gokahmetoglu S; Güven K; Idilman R; Yurdaydin C; Bozdayi AM
J Clin Virol; 2012 Feb; 53(2):130-4. PubMed ID: 22078148
[TBL] [Abstract][Full Text] [Related]
29. Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy in human immunodeficiency virus coinfected patients: performance of CLIP sequencing and line probe assay.
Roque-Afonso AM; Férey MP; Mackiewicz V; Fki L; Dussaix E
Antivir Ther; 2003 Dec; 8(6):627-34. PubMed ID: 14760897
[TBL] [Abstract][Full Text] [Related]
30. Five-year data released for entecavir.
AIDS Patient Care STDS; 2008 Apr; 22(4):349. PubMed ID: 18422464
[No Abstract] [Full Text] [Related]
31. [Entecavir resistance in entecavir naive lamivudine treated chronic hepatitis B patients].
Sayan M; Hülagü S; Akhan SC; Sentürk O; Meriç M; Cekmen M
Mikrobiyol Bul; 2009 Jul; 43(3):425-32. PubMed ID: 19795617
[TBL] [Abstract][Full Text] [Related]
32. Acute hepatitis B infection associated with drug-resistant hepatitis B virus.
Xu Z; Liu Y; Xu T; Chen L; Si L; Wang Y; Ren X; Zhong Y; Zhao J; Xu D
J Clin Virol; 2010 Aug; 48(4):270-4. PubMed ID: 20580309
[TBL] [Abstract][Full Text] [Related]
33. Virological response and antiviral resistance mutations in chronic hepatitis B subjects experiencing entecavir therapy: an Indian subcontinent perspective.
Ismail AM; Sharma OP; Kumar MS; Eapen CE; Kannangai R; Abraham P
Antiviral Res; 2013 May; 98(2):209-16. PubMed ID: 23485939
[TBL] [Abstract][Full Text] [Related]
34. [YMDD motif variants detected by Inno-Lipa HBV DR assay in chronic hepatitis B patients during lamivudine therapy].
Arslan U; Ural O; Findik D
Mikrobiyol Bul; 2008 Jul; 42(3):445-50. PubMed ID: 18822888
[TBL] [Abstract][Full Text] [Related]
35. Performance of sequence analysis, INNO-LiPA line probe assays and AFFIGENE assays in the detection of hepatitis B virus polymerase and precore/core promoter mutations.
Olivero A; Ciancio A; Abate ML; Gaia S; Smedile A; Rizzetto M
J Viral Hepat; 2006 Jun; 13(6):355-62. PubMed ID: 16842437
[TBL] [Abstract][Full Text] [Related]
36. INNO-LiPA HBV genotyping is highly consistent with direct sequencing and sensitive in detecting B/C mixed genotype infection in Chinese chronic hepatitis B patients and asymptomatic HBV carriers.
Yang R; Cong X; Xu Z; Xu D; Huang W; Maertens R; Wei L
Clin Chim Acta; 2010 Dec; 411(23-24):1951-6. PubMed ID: 20709042
[TBL] [Abstract][Full Text] [Related]
37. Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.
Leemans WF; Niesters HG; van der Eijk AA; Janssen HL; Schalm SW; de Man RA
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):773-7. PubMed ID: 18617782
[TBL] [Abstract][Full Text] [Related]
38. An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus.
Hu Y; Zhang WL; Xie SL; Zhao Y; Hu JL; Cai XF; Lai GQ; Huang AL
Genet Mol Res; 2012 Jan; 11(1):53-60. PubMed ID: 22290465
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous emergence of entecavir resistance mutations in a nucleoside-naive chronic hepatitis B patient.
Lee HW; Kim HJ; Hong SP; Cha BK; Chang HY; Choi CH; Do JH; Kim JG; Chang SK
Intervirology; 2012; 55(5):380-4. PubMed ID: 22538265
[TBL] [Abstract][Full Text] [Related]
40. [Hepatitis B virus resistance to entecavir].
Hidalgo-Tenorio C; Rivero M; Alvarez M; García F
Med Clin (Barc); 2012 Jul; 139(5):228-9. PubMed ID: 22401720
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
